If successful, it would be the first new class of drug against certain bacteria strains for more than fifty years ...

The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...

Halfway through President Donald Trump's 90-day freeze on his so-called reciprocal tariffs, a persistent gripe is severe ...

Tandem Diabetes Care has agreed to pay Roche Holding $36 million to settle a patent infringement claim. The two companies have granted each other licenses to patents on the insulin delivery systems in ...

Roche, hoping to carve out a standard-of-care spot for its PI3K inhibitor Itovebi, now has another leg to stand on with new ...

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in ...

Key Takeaways Since tariffs were announced, a number of companies have announced multibillion-dollar investments in U.S.

The heiress, Claudia Engelhorn, has said that the gift was "alcohol induced." She's now suing Erik Bolog and his former firm.

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

Log-hub appoints Richard Groenenboom to its Board of Directors, bringing 30+ years of Pharma and Supply Chain leadership to strengthen industry alignment.

Morristown-based Sanofi will be the latest U.S drugmaker to inject billions of dollars into domestic operations and American manufacturing.